To include your compound in the COVID-19 Resource Center, submit it here.

Aldeyra raises $28.8M follow-on

Aldeyra Therapeutics Inc. (NASDAQ:ALDX), which focuses on diseases related to aldehydes, raised

Read the full 120 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE